The 5′-phosphoramidate of ATI-2173 generates the 5′-monophosphate bypassing the first phosphorylation step of clevudine, which uses the TK2 enzyme and may be responsible for the reversible skeletal myopathy seen in chronically dosed patients (15, 17, 45). The gene discussed is TK2; the disease is skeletal muscle disorder.